Use of Novel Biomarkers of P. Gingivalis Infection & Neuroinflammation in the GAIN Trial; An Ongoing Phase 2/3 Clinical Trial Assessing the Activity of Atuzaginstat in Patients with Mild to Moderate Alzheimer’s Disease

Time: 2:10 pm
day: Day One


  • Application of mechanism-specific biomarkers in a trial targeting an infectious pathogen found in the brain of Alzheimer’s patients and tied to neurodegeneration and neuroinflammation
  • Development of novel biomarkers that assess baseline subject characteristics which may be predictive of response
  • Clinical update on baseline biomarker analysis and subject characterization in the GAIN trial with CSF and blood-based biomarkers